Sarah Moser
PhD candidate / self funded
- Name
- Dr. S.C. Moser
- Telephone
- 071 5272727
- s.c.moser@lacdr.leidenuniv.nl
PhD candidate / self funded
- Faculty of Science
- LACDR
- Divisie Cell systems and Drug Safety
- Khalizieva A., Moser S.C., Bouwman R.J.P. & Jonkers J.M.M. (2025), BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality, Genes & Development 39: 86-108.
- Moser S.C., Khalizieva A., Roehsner J., Pottendorfer E., Kaptein M.L., Ricci G., Bhardwaj V., Bleijerveld O.B., Hoekman L., Heijden I. van der, di Sanzo S., Fish A., Chikunova A., Haarhuis J.H.I., Oldenkamp R., Robbez-Masson L., Sprengers J., Vis D.J., Wessels L.F.A., Ven M. van de, Pettitt S.J., Tutt A.N.J., Lord C.J., Rowland B.D., Völker-Albert M., Mattiroli F., Brummelkamp T.R., Mazouzi A. & Jonkers J.M.M. (2025), NASP modulates histone turnover to drive PARP inhibitor resistance, Nature 645: 1071-1080.
- Moser S.C. (14 November 2025), New dimensions of the cellular response to DNA damage (Dissertatie. Leiden Academic Centre for Drug Research (LACDR), Faculty of Science, Leiden University). Supervisor(s) and Co-supervisor(s): Jonkers J.M.M., Rottenberg S.
No relevant ancillary activities